CFB
NGVT icon

Cullen/Frost Bankers’s Ingevity NGVT Stock Holding History

Cullen/Frost Bankers’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16
Closed -$1.14K – 1466
2026
Q1 		$1.14K Hold
16
– – ﹤0.01% 1300
2025
Q4 		$947 Hold
16
– – ﹤0.01% 1310
2025
Q3 		$883 Sell
16
-36
-69% -$1.87K ﹤0.01% 1271
2025
Q2 		$2.24K Sell
52
-153
-75% -$5.9K ﹤0.01% 1167
2025
Q1 		$8.12K Buy
+205
New +$9.07K ﹤0.01% 979
2020
Q3 		– Sell
-100
Closed -$5K – 1232
2020
Q2 		$5K Buy
+100
New +$4.75K ﹤0.01% 964
2019
Q2 		– Sell
-1
Closed – – 1086
2019
Q1 		$0 Buy
+1
New +$100 ﹤0.01% 956

Other funds holding NGVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Cullen/Frost Bankers's NGVT Position: Q2 2026 in Review

Cullen/Frost Bankers sold out of Ingevity (NGVT) in Q2 2026, closing a stake of 16 shares — an estimated $1.14K sold.

Cullen/Frost Bankers first reported a position in NGVT in Q1 2019 and held it in 7 quarters. The position peaked at $8.12K in Q1 2025. 316 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Cullen/Frost Bankers reported no remaining Ingevity position as of Q2 2026 after selling out during the quarter.
  • Cullen/Frost Bankers sold 16 Ingevity shares in Q2 2026, an estimated $1.14K.
  • Cullen/Frost Bankers first reported a position in Ingevity in Q1 2019 and held it in 7 quarters.
  • Cullen/Frost Bankers's Ingevity position peaked at $8.12K in Q1 2025.
  • 316 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.